367 related articles for article (PubMed ID: 30052270)
1. Pharmacokinetic and Pharmacodynamic Evaluation of Intravenous Levetiracetam in Children With Epilepsy.
Kim MJ; Yum MS; Yeh HR; Ko TS; Lim HS
J Clin Pharmacol; 2018 Dec; 58(12):1586-1596. PubMed ID: 30052270
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics and dose-response relationship of levetiracetam in adult patients with epilepsy.
Rhee SJ; Shin JW; Lee S; Moon J; Kim TJ; Jung KY; Park KI; Lee ST; Jung KH; Yu KS; Jang IJ; Chu K; Lee SK
Epilepsy Res; 2017 May; 132():8-14. PubMed ID: 28279893
[TBL] [Abstract][Full Text] [Related]
3. Brivaracetam exposure-response predictions in pediatric patients from age 1 month: Extrapolation of levetiracetam adult-pediatric scaling to brivaracetam.
Schoemaker R; Krauwinkel W; Elshoff JP; Stockis A
Epilepsy Res; 2024 May; 202():107332. PubMed ID: 38518434
[TBL] [Abstract][Full Text] [Related]
4. Population pharmacokinetics of levetiracetam and dosing recommendation in children with epilepsy.
Chhun S; Jullien V; Rey E; Dulac O; Chiron C; Pons G
Epilepsia; 2009 May; 50(5):1150-7. PubMed ID: 19175400
[TBL] [Abstract][Full Text] [Related]
5. Comparison of long-term efficacy, tolerability, and safety of oxcarbazepine, lamotrigine, and levetiracetam in patients with newly diagnosed focal epilepsy: An observational study in the real world.
Li R; Zhou Q; Ou S; Wang Y; Li Y; Xia L; Pan S
Epilepsy Res; 2020 Oct; 166():106408. PubMed ID: 32679487
[TBL] [Abstract][Full Text] [Related]
6. Psychiatric and behavioral concerns of perampanel with concomitant levetiracetam in children with epilepsy.
Kim JS; Kim WS; Sung WY; Woo H
Epilepsy Behav; 2024 May; 154():109740. PubMed ID: 38547767
[TBL] [Abstract][Full Text] [Related]
7. Levetiracetam in children with refractory epilepsy: lack of correlation between plasma concentration and efficacy.
Giroux PC; Salas-Prato M; Théorêt Y; Carmant L
Seizure; 2009 Oct; 18(8):559-63. PubMed ID: 19546014
[TBL] [Abstract][Full Text] [Related]
8. Levetiracetam monotherapy in children with epilepsy: Experience from a tertiary pediatric neurology center.
Yıldırım M; Bektaş Ö; Akıncı Göktaş Ö; Yüksel MF; Şahin S; Tıraş Teber S
Epilepsy Behav; 2021 Mar; 116():107745. PubMed ID: 33508749
[TBL] [Abstract][Full Text] [Related]
9. Initial levetiracetam versus valproate monotherapy in antiseizure medicine (ASM)-naïve pediatric patients with idiopathic generalized epilepsy with tonic-clonic seizures.
Abdelmesih SK; Elkhateeb N; Zakaria M; Girgis MY
Seizure; 2021 Oct; 91():263-270. PubMed ID: 34246881
[TBL] [Abstract][Full Text] [Related]
10. Usefulness of perampanel with concomitant levetiracetam for patients with drug-resistant epilepsy.
Kanemura H; Sano F; Aihara M
Eur J Paediatr Neurol; 2019 Jan; 23(1):197-203. PubMed ID: 30424990
[TBL] [Abstract][Full Text] [Related]
11. The effect of serum levetiracetam concentrations on therapeutic response and IL1-beta concentration in patients with epilepsy.
Gulcebi MI; Kendirli T; Turgan ZA; Patsalos PN; Onat Yilmaz F
Epilepsy Res; 2018 Dec; 148():17-22. PubMed ID: 30326332
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of perampanel and levetiracetam as first add-on therapy in patients with epilepsy: A retrospective single center study.
Liguori C; Izzi F; Manfredi N; D'Elia A; Mari L; Mercuri NB; Fabio P
Epilepsy Behav; 2018 Mar; 80():173-176. PubMed ID: 29414548
[TBL] [Abstract][Full Text] [Related]
13. Effectiveness of Levetiracetam Monotherapy in Pediatric Patients With Epilepsy.
Mazur RD; Wang Ba Q; Kato Bs K; Buchsbaum Bs R; Bonito Bs J; Choi H; Hirsch L; Detyniecki K
J Child Neurol; 2019 Sep; 34(10):593-597. PubMed ID: 31113283
[TBL] [Abstract][Full Text] [Related]
14. Lipid and thyroid hormone levels in children with epilepsy treated with levetiracetam or carbamazepine: A prospective observational study.
Nishiyama M; Takami Y; Ishida Y; Tomioka K; Tanaka T; Nagase H; Nakagawa T; Tokumoto S; Yamaguchi H; Toyoshima D; Maruyama A; Nozu K; Nishimura N; Iijima K
Epilepsy Behav; 2019 Jan; 90():15-19. PubMed ID: 30500483
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of levetiracetam in children younger than 4 years: a retrospective review.
Perry MS; Benatar M
Epilepsia; 2007 Jun; 48(6):1123-7. PubMed ID: 17430408
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic drug monitoring in pregnancy: Levetiracetam.
Fallik N; Trakhtenbroit I; Fahoum F; Goldstein L
Epilepsia; 2024 May; 65(5):1285-1293. PubMed ID: 38400747
[TBL] [Abstract][Full Text] [Related]
17. Intravenous levetiracetam in clinical practice--Results from an independent registry.
Lang N; Esser W; Evers S; Kellinghaus C; Nguento A; Schlegel U; Gaida B; Gburek-Augustat J; Altenmüller DM; Burghaus L; Hoffmann F; Fiedler B; Bast T; Rehfeld T; Happe S; Seitz RJ; Boor R; Stephani U
Seizure; 2015 Jul; 29():109-13. PubMed ID: 26076852
[TBL] [Abstract][Full Text] [Related]
18. Evidence for sustained efficacy of levetiracetam as add-on epilepsy therapy.
Ben-Menachem E; Edrich P; Van Vleymen B; Sander JW; Schmidt B
Epilepsy Res; 2003 Feb; 53(1-2):57-64. PubMed ID: 12576168
[TBL] [Abstract][Full Text] [Related]
19. [Follow-up study on levetiracetam monotherapy in children with epilepsy].
Gao ZJ; Jiang YW
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):711-4. PubMed ID: 19102836
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Controlled Trial of Phenobarbital and Levetiracetam in Childhood Epilepsy.
Akter N; Rahman MM; Akhter S; Fatema K
Mymensingh Med J; 2018 Oct; 27(4):776-784. PubMed ID: 30487494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]